<?xml version="1.0" encoding="UTF-8"?><add><doc><field name="id">0003071</field><field name="title">CYTRX [CYTR] UNIT BUYS SWEDISH COMPANY</field><field name="place">ATLANTA</field><field name="date">March 12</field><field name="content">- CytRx Corp said its 60 pct owned CytRx Biopool Ltd subsidiary has acquired Biopool AB of Umea, Sweden, for undisclosed terms.     It said former shareholders of Biopool AB own the remaining 40 pct in CytRx Biopool Ltd. Biopool AB develops cardiovascular and fibrinolytic products for diagnostic applications.     The company said CytRx Biopool is studying the possible combination of CytRx Corp's RheothRx drug to reduce platelet aggregation and viscosity in blood with Biopool AB's drug t-PA for dissolving blood clots. </field></doc></add>